Heart rate variability analysis in acute poisoning by cholinesterase inhibitors by JINWOO JEONG & YONGIN KIM
       SIGNA VITAE    |    33
Heart rate variability analysis in acute poisoning by 
cholinesterase inhibitors
YONGIN KIM1, JINWOO JEONG2
1 Department of Emergency Medicine, Pusan National University Yangsan Hospital
2 Department of Emergency Medicine, College of Medicine, Dong-A University 
Corresponding author 
Jinwoo Jeong
Department of Emergency Medicine
Dong-A University Hospital





Heart rate variability (HRV) has been asso-
ciated with a variety of clinical situations. 
However, few studies have examined the 
association between HRV and acute poi-
soning. Organophosphate (OP) and car-
bamate inhibit esterase enzymes, particu-
larly acetylcholinesterase, resulting in an 
accumulation of acetylcholine and thereby 
promoting excessive activation of corre-
sponding receptors. Because diagnosis and 
treatment of OP and carbamate poisoning 
greatly depend on the severity of choliner-
gic symptoms, and because HRV reflects 
autonomic status, some HRV parameters 
may be of value in diagnosing OP and car-
bamate poisoning among patients visiting 
the emergency department.
Patients who visited the emergency de-
partment of the study hospital between 
September 2008 and May 2010 with the 
chief complaint of acute poisoning or over-
dose were included. Cases that involved 
ingestion of OP or carbamate insecticides 
were classified as poisoning by cholinest-
erase inhibitors and compared with other 
cases of poisoning or overdose. The time-
domain analysis included descriptive sta-
tistics of R-R intervals and instantaneous 
heart rates. The frequency-domain analy-
sis used fast Fourier transformation. A 
Poincaré plot, which is a scatterplot of R-R 
intervals against the preceding R-R inter-
val, was used for the nonlinear analysis.
Very-low-frequency (VLF) power and the 
ratio of low-frequency-to-high-frequency 
power (LF/HF) were the most effective pa-
rameters for distinguishing cholinesterase 
inhibitor poisoning among cases of acute 
poisoning, with areas under the receiver-
operating characteristic curve of 0.76 and 
0.87, respectively. Cholinesterase inhibitor 
poisoning was a significant factor deter-
mining VLF power and the LF/HF ratio 
after adjusting for possible confounding 
variables, including age over 40, gender, 
and tracheal intubation.
Frequency-domain parameters of HRV, 
such as VLF power and the LF/HF ratio, 
might be considered as potential diagnos-
tic methods to distinguish cholinesterase 
inhibitor poisoning from other cases of in-
toxication in the early stages of emergency 
care.
Key words: electrocardiography, organo-
phosphates, carbamates, poisoning
INTRODUCTION
Heart rate dynamically responds to physi-
ologic alterations, mediated by the au-
tonomic nervous system via vagal and 
sympathetic nerve impulses. (1) Analysis 
of heart rate variability (HRV) using elec-
trocardiographic (ECG) recording is an 
important method used to assess cardio-
vascular autonomic regulation. HRV has 
been associated with a variety of clinical 
situations such as mortality due to acute 
myocardial infarction, severity of trauma, 
diabetic neuropathy, outcome of prehos-
pital ambulance patients, etc. (1-4)  How-
ever, little research has examined the asso-
ciation between HRV and acute poisoning, 
except for antidepressant overdoses. (5,6)
Many parameters used to quantify HRV 
have been introduced and are categorized 
into time domain, frequency domain, and 
nonlinear parameters. Table 1 summarizes 
HRV parameters with a brief description 
of each. Time domain parameters are the 
most simple to analyze and are derived 
from statistical representation of R-R in-
tervals or differences in consecutive R-R 
intervals. Frequency domain parameters 
are derived from power spectral density 
analysis and provide information on how 
power (variance) distributes as a func-
tion of frequency. (1,4) It was reported 
that when parasympathetic activity is 
blocked, both LF and HF (low-frequency, 
high-frequency) values decrease, while LF 
power decreases by sympathetic blockade. 
(7) However, the effects of pharmacologic 
overstimulation of autonomic systems are 
not well-known. The Poincaré plot is one 
of several nonlinear methods used to ana-
lyze HRV, which is a scatterplot of the cur-
rent R-R interval plotted against the pre-
ceding R-R interval. The Poincaré plot is 
thought to be able to identify beat-to-beat 
patterns in data that are difficult to iden-
tify using frequency-domain analysis and 
can be quantified by standardized devia-
tions along and perpendicular to the line 
of identity. (8) 
Organophosphate (OP) and carbamate 
agents are widely used as pesticides in 
Asia. These compounds inhibit esterase 
enzymes, particularly acetylcholinesterase 
in synapses and on red cell membranes 
and butyrylcholinesterase in plasma. 
(9,10) Acetylcholinesterase inhibition re-
sults in an accumulation of acetylcholine 
and thereby promotes excessive activation 
of corresponding receptors in synapses 
of the autonomic nervous system, central 
nervous system (CNS), and neuromus-
cular junctions. (9) Symptoms of OP and 
carbamate poisoning include cholinergic 
crisis, CNS dysfunction, and neuromus-
cular paralysis. (9,11) Because diagnosis 
and treatment of OP and carbamate poi-
soning greatly depend on the severity of 
cholinergic symptoms and because HRV 
reflects autonomic status, the authors hy-
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pothesized that some HRV parameters 
may be of value in diagnosing OP and car-
bamate poisoning among patients visiting 
the emergency department (ED); thus, we 




Th is study was approved by the Institu-
tional Review Board of the Pusan National 
University Hospital, and the need for writ-
ten informed consent was waived by the 
Institutional Review Board because of the 
noninvasiveness of the study and imprac-
ticality of obtaining written consent in 
emergency settings. Patients who visited 
the emergency department of the study 
hospital between September 2008 and May 
2010 with the chief complaint of acute 
poisoning or overdose were included. Th e 
ingested substances were identifi ed by the 
patients or accompanying guardians if the 
patients were not communicable. Cases 
of pesticide poisoning were included only 
when the containers were identifi ed. Cases 
that involved ingestion of organophos-
phate or carbamate insecticides were con-
sidered to be poisoning by cholinesterase 
inhibitors and were compared with other 
cases of poisoning or overdose.
A custom-built data-sampling device 
was connected to the analog ECG output 
port of a Lifepak 20 monitor–defi brilla-
tor (Physio-control, Redmond, WA). Th e 
device sampled the ECG signal at a rate 
of 1,000 Hz and transmitted the voltage 
data to a personal computer in numbers 
via Bluetooth wireless connection. On 
the personal computer, signal-receiving 
and -converting soft ware that had been 
programmed by the authors stored the 
data in the form of a text fi le. Th e text fi le 
with the raw signal data was imported to 
the Physio Toolkit, (12) and R-R intervals 
were extracted from the ECG tracings. Th e 
quality of the ECG tracings and the valid-
ity of R-R interval extraction were manu-
ally verifi ed by the author. Data with un-
suitable quality to accurately determine R 
wave peaks due to artifacts and cases with 
atrial fi brillation were excluded from fur-
ther analysis. Th e R-R intervals used for 
analyses were acquired from a 5-min pe-
riod representing the earliest period of the 
patients’ stay in the emergency department 
that provided data of appropriate quality. 
Emergency treatments, including tracheal 
intubation, intravenous access, and fi rst 
dose of an antidote such as atropine, were 
given prior to signal acquisition. Th e HRV 
parameters used for analyses are summa-
rized in table 1. Th e time-domain analysis 
included descriptive statistics of R-R in-
tervals and instantaneous heart rates. Th e 
frequency-domain analysis utilized fast 
Fourier transformation. Power spectral 
density against frequency is presented as 
a nonparametric Welch’s periodogram. A 
Poincaré plot, which is a scatterplot of R-R 
intervals against the preceding R-R inter-
val, was used for the nonlinear analysis of 
beat-to-beat patterns.
Gender, age, type and amount of ingested 
poisons, and prior treatments were ex-
tracted from medical records. Continu-
ous variables with a normal distribution 
are presented as means and standard de-
viation (SD) and variables that do not 
conform to normal distribution are pre-
sented as median values with interquar-
tile range. We compared data from cases 
of cholinesterase poisoning with other 
poisonings, because HRV parameters are 
sensitive to stress conditions, and stand-
ard normal and abnormal values cannot 
be defi ned, since the dynamic equilibrium 
of autonomic balance and its range of ex-
cursion can be extremely wide. (13) Cat-
egorical variables were compared using the 
chi-square test. Numerical variables were 
evaluated for normal distribution with the 
Shapiro-Wilk test, and thereaft er a t-test 
or Mann-Whitney test were used for com-
parison, as appropriate. Receiver operating 
characteristic (ROC) curves were used to 
evaluate the diagnostic utility of HRV pa-
rameters for the diagnosis of cholinester-
ase inhibitor poisoning. Th e ROC curve is 
defi ned as a plot of test sensitivity as the 
y coordinate versus its 1-specifi city as the 
x coordinate and is an eff ective method of 
evaluating the performance of diagnostic 
tests. (14,15) Logistic regression analysis 
was used to determine the eff ects of pos-
sible confounding variables. Th e depend-
ent variables were categorized as whether 
the HRV parameter of concern was above 
or below the proposed cutoff  value. Th e 
independent variables included age over 
40, gender, whether the patient had altered 
consciousness or was intubated prior to 
HRV analysis, and whether the ingested 
toxin was a cholinesterase inhibitor.
HRV Analysis Soft ware 1.1 (Biomedi-
cal Signal Analysis Group, Department 
of Applied Physics, University of Kuopio, 
Finland), (16) was used for the HRV analy-
sis. MedCalc soft ware (ver. 15.6; MedCalc 
Soft ware, Mariakerke, Belgium) was used 
for the statistical analyses. Statistical sig-




During the study period, a total of 110 cas-
es were considered for inclusion. Among 
these, 27 cases were excluded because of 
poor signal quality, atrial fi brillation, and 
unknown toxins (fi gure 1). 
Figure 1. Flowchart of patient inclusion.
In total, 83 patients were included in the 
analyses; 45 (54.2%) were males, and 38 
(45.8%) were females. Th e mean age of the 
patients was 48.5 (SD: 17.0) years. Among 
the 83 patients, eight had ingested cho-
linesterase inhibitors, and the other 75 had 
ingested various other substances. None 
of the eight patients with cholinesterase 
inhibitor poisoning had co-ingested other 
toxic materials. Th e ingested poisons are 
listed in table 2. Baseline characteristics 
and HRV parameters are summarized in 
table 3. Gender and age were not signifi -
cantly diff erent between the two groups. 
However, consciousness measured with 
AVPU (alert, verbal, pain, unresponsive) 
scale was worse in the cases with cholinest-
erase inhibitor poisoning, because cho-
linesterase inhibitors act as central nerve 
system depressants (p=0.013).  All patients 
intoxicated with cholinesterase inhibitors 
received tracheal intubation, while only 
36% of the other poisoned patients were 
intubated, (p=0.001), which indicates the 
severe toxicity of cholinesterase inhibitors. 
Among the HRV parameters, only Very-
low-frequency (VLF) power and the LF/
HF ratio had signifi cance and were lower 
in the patients poisoned by cholinesterase 
inhibitors (fi gure 2). 
Th e clinical and HRV characteristics of 
overdoses with common occurrence are 
listed in table 4. HRV parameters did not 
diff er much between groups, although 
statistical comparison was not possible 
because of substantial co-ingestions be-
tween these drugs. Poincaré plot samples 
are displayed in fi gure 3 for visual refer-
ence, although statistical signifi cance was 
not found. 
Th e ROC curve analyses were conducted 
to determine the diagnostic value of VLF 
power and the LF/HF ratio, which ap-
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peared to be eff ective parameters, with 
areas under the ROC curve (AUC) val-
ues of 0.76 (95% confi dence interval [CI], 
0.65–0.85; p=0.045) and 0.87 (95% CI, 
0.78–0.94; p<0.001), respectively (fi gure 
2). When a criterion of < 1.14 ms2 was 
used for VLF power, the sensitivity and 
specifi city were 75.0% (95% CI, 34.9–96.8) 
and 89.3% (95% CI, 80.1–95.3), respective-
ly. Th e optimal cutoff  value for the LF/HF 
ratio was 0.82 with a sensitivity of 100.0% 
(95% CI, 63.1–100.0) and specifi city of 
69.3% (95% CI, 57.6–79.5).
Th e results of the logistic regression analy-
ses are summarized in table 5 and table 6. 
Cholinesterase inhibitor poisoning was a 
signifi cant factor determining VLF power 
and the LF/HF ratio aft er adjusting for 
possible confounding variables, including 
age over 40, gender, and tracheal intuba-
tion. Another signifi cant variable noted by 
logistic regression analysis was tracheal in-
tubation, while age and gender were found 
to be insignifi cant. 
Table 1. List of HRV parameters used in the analyses (2,4,8,26).
Parameter Description
Time-domain analysis
SDNN (s) Standard deviation of R-R intervals
RMSSD (s) Root of mean squared diff erences between adjacent R-R intervals
NN50 (count) Number of interval diff erences greater than 50 ms in consecutive R-R 
intervals 
pNN50 (%) Proportion of NN50 to total number of R-R intervals
Frequency-domain analysis
VLF (ms2) Power in the very-low-frequency range (≤ 0.04 Hz)
LF (ms2) Power in the low-frequency range (0.04–0.15 Hz)
HF (ms2) Power in the high-frequency range (0.15–0.40 Hz)
LF/HF Ratio of LF-to-HF
Poincaré plot analysis
Width Standard deviation of points perpendicular to the line of identity
Length Standard deviation of points along the line of identity
Length/width Proportion of length to width
HRV, heart rate variability.
Values are presented as means ± standard deviation
Figure 2. Welch’s periodogram representing 
the frequency-domain analysis of a case of 
poisoning by (a) a cholinesterase inhibi-
tor, (b) glyphosate herbicide, (c) benzo-
diazepine, and (d) zolpidem. Th e power 
spectrum patterns from cases of cholinest-
erase poisoning show decreased very-low-
frequency and low-frequency power. 
PSD, power spectrum density.
Figure 3. Poincaré plot of a case of 
poisoning by (a) a cholinesterase inhibitor, 
(b) glyphosate herbicide, (c) benzodiaz-
epine, and (d) zolpidem. Th e plots are 
presented for visual reference. Quantized 
parameters were not statistically signifi -
cant.
Figure 4. Receiver-operating characteristic 
curves of (a) very-low-frequency power 
and (b) the low-frequency-to-high-frequen-
cy power ratio for the diagnosis of 
poisoning by cholinesterase inhibitors.
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Table 2. Ingested substances and number of exposures.
Substance ingested Number of exposures (%)
Cholinesterase inhibitors
Organophosphate insecticides 5 (6.0)
Carbamate insecticides 3 (3.6)




Non-steroidal anti-inflammatory drugs 4 (4.8)
Beta-adrenergic blockers 3 (3.6)







Cyclic antidepressants 3 (3.6)
Selective serotonin reuptake inhibitors 11 (13.3)
Serotonin antagonist and reuptake inhibitors 3 (3.6)







Benzoylurea insecticide 1 (1.2)
Methoxy insecticide 1 (1.2)





Note: The numbers do not add up to the total number of patients (83) because some patients ingested more than one substance.
 
Table 3. Baseline characteristics and heart rate variability parameters of patients with cholinesterase inhibitor poisoning and other poison-
ings. Categorical variables are presented as the frequency and percentage. Numerical variables are presented as means ± standard devia-
tion or as median values (interquartile range), as appropriate.
Cholinesterase inhibitor poison-





  Male 6 (75.0) 39 (52.0)
  Female 2 (25.0) 36 (48.0)
Age (years) 59.5±11.6 48.1±16.7 NS**
Consciousness 0.013*
Alertness 1 (12.5) 34 (45.3)
Response to verbal stimuli 2 (25.0) 18 (24.0)
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Response to pain 2 (25.0) 19 (25.3)
Unresponsive 2 (37.5) 4 (5.3)
Tracheal intubation 8 (100.0) 27 (36.0) 0.001*
Time-domain analysis
SDNN (s) 0.03 (0.01–0.04) 0.02 (0.01–0.03) NS**
RMSSD (s) 34.28 (9.86–54.71) 17.58 (9.15–29.32) NS**
NN50 (count) 13 (4.50–44.50) 3 (1.0–10.0) NS**
pNN50 (%) 2.12 (0.72–7.51) 0.81 (0.18–2.22) NS**
Frequency-domain analysis
VLF (ms2) 0.67 (0.20–49.87) 24.69 (4.71–77.95) 0.016***
LF (ms2) 1.26 (0.69–252.70) 21.31 (2.53–67.97) NS***
HF (ms2) 11.29 (3.43–332.22) 11.38 (1.95–46.15) NS***
LF/HF 0.24 (0.10–0.68) 1.39 (0.58–3.85) 0.001***
Poincaré plot analysis
Width 28.48 (9.75–43.01) 14.73 (6.97–23.63) NS***
Length 25.71 (9.237–45.612) 34.46 (19.31–59.00) NS***
Length/width 1.24 (0.73–2.11) 1.77 (0.84–3.67) NS
Abbreviations are the same as in table 1. 
* Compared with chi-square test
** Compared with independent sample t-test
*** Compared with Mann-Whitney test
Table 4. Clinical and heart rate variability parameters of overdoses of larger cases. 
Benzodiazepines (n = 20) Zolpidem (n = 12) SSRI* (n = 11)
Gender
  Male 8 (40.0) 2 (16.7) 4 (36.4)
  Female 12 (60.0) 10 (83.3) 7 (63.6)
Age (years) 43.5±17.5 44.1±19.2 36.8±14.4
Consciousness
  Alertness 6 (30.0) 4 (33.3) 3 (27.3)
  Response to verbal stimuli 8 (40.0) 3 (25.0) 4 (36.4)
  Response to pain 6 (30.0) 5 (41.7) 4 (36.4)
  Unresponsive 0 (0.0) 0 (0.0) 0 (0.0)
Tracheal intubation 6 (30.0) 5 (41.7) 3 (27.3)
Time-domain analysis
  SDNN (s) 0.03 (0.02-0.05) 0.02 (0.01-0.03) 0.28 (0.01-0.05)
  RMSSD (s) 18.61 (8.05-34.35) 14.34 (6.42-21.79) 22.21 (10.91-50.16)
  NN50 (count) 2 (0.00-8.50) 3 (0.00-9.50) 2 (1.00-15.00)
  pNN50 (%) 0.75 (0.00-2.40) 0.63 (0.00-1.95) 0.73 (0.19-3.62)
Frequency-domain analysis
  VLF (ms2) 35.92 (14.21-148.76) 53.01 (7.22-201.85) 24.06 (15.03-168.73)
  LF (ms2) 35.02 (16.13-99.04) 33.41 (1.16-66.74) 27.27 (11.67-107.89)
  HF (ms2) 18.70 (4.08-63.37) 5.87 (0.83-42.59) 11.38 (4.03-94.71)
  LF/HF 1.25 (0.83-5.37) 1.23 (0.63-7.08) 1.08 (0.88-3.24)
Poincaré plot analysis
  Width 14.96 (8.69-25.32) 10.69 (4.87-15.89) 16.29 (7.85-36.04)
  Length 46.72 (30.49-74.44) 49.05 (24.47-82.45) 53.06 (27.67-78.30)
  Length/width 2.33 (0.89-3.51) 5.62 (3.14-9.61) 1.82 (0.83-3.47)
Abbreviations are the same as in table 1. *SSRI: selective serotonin reuptake inhibitor
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Table 5. Multivariate logistic regression models used to determine an association between cholinesterase inhibitor poisoning and very-low 
frequency power (VLF) below the proposed cutoff value (1.137 ms2) adjusted for gender, age over 40, alertness, and prior tracheal intuba-
tion. The total number of cases is 83; VLF < 1.137 ms2 cases are 14; VLF ≥ 1.137 ms2 cases are 69. 
Variable Coefficient S.E.* p-value Odds ratio (95% CI**)
Cholinesterase inhibitor 
poisoning
2.13 0.96 0.027 8.40 (1.28-55.15)
Male gender 0.11 0.75 0.887 1.11 (0.26-4.83)
Age over 40 1.24 1.14 0.280 3.44 (0.37-32.30)
Tracheal intubation 1.81 0.87 0.037 6.14 (1.12-33.60)
Constant -4.21 1.77 0.017 Not applicable
Model chi-square = 22.56 (p < 0.001)
Nagelkerke R2 = 0.40
Hosmer and Lemeshaw p = 0.613
*S.E.: standard error   **CI: confidence interval
 
Table 6. Multivariate logistic regression models used to determine an association between cholinesterase inhibitor poisoning and the ratio 
of low-frequency power to high-frequency power (LF/HF) below the proposed cutoff value (0.82) adjusted for gender, age over 40, alert-
ness, and prior tracheal intubation. The total number of cases was 83; LF/HF < 0.82 cases were 30; LH/HF ≥ 0.82 cases were 53. 
Variable Coefficient S.E.* p-value Odds ratio (95% CI**)
Cholinesterase inhibitor 
poisoning
2.42 1.17 0.038 11.22 (1.15-110.05)
Male gender 0.89 0.53 0.098 2.42 (0.85-6.90)
Age over 40 -0.06 0.57 0.910 0.94 (0.31-2.86)
Tracheal intubation 1.09 0.54 0.042 2.98 (1.04-8.55)
Constant -2.55 1.05 0.015 Not applicable
Model chi-square = 16.84 (p = 0.002)
Nagelkerke R2 = 0.25
Hosmer and Lemeshaw p = 0.995
*S.E.: standard error   **CI: confidence interval
DISCUSSION
HRV was first appreciated as a clinical tool 
for monitoring fetal distress in 1965. (4) 
Currently, the association of HRV and au-
tonomic function is widely appreciated in 
clinical medicine. (1-4,13,17-21) As auto-
nomic dysfunction largely characterizes the 
symptoms caused by cholinesterase inhibi-
tor intoxication, HRV may be of diagnostic 
value in cases of pesticide poisoning. Our 
data showed that HRV parameters, par-
ticularly frequency-domain results of the 
VLF and LF/HF areas, were associated with 
organophosphate and carbamate poison-
ing.
This study demonstrated that the time-do-
main analyses were not significant. Time-
domain results are usually indicators of 
gross variation in the R-R interval and are 
attributed to the respiratory cycle. (1,2,4) 
To assess specific autonomic dysfunction, 
more sophisticated analyses, such as trans-
formation to frequency domain, would be 
needed.
There is some debate regarding the inter-
pretation of frequency-domain results, 
but it is generally believed that HF power 
reflects ventilator modulation of R-R in-
tervals, and LF power is modulated by 
both sympathetic and parasympathetic 
nerve traffic to the heart. (1,4) Although 
LF power and HF power alone did not 
have significant diagnostic value based on 
the ROC curve, the LF/HF ratio exhibited 
good sensitivity and specificity. A possible 
explanation could be that the overwhelm-
ing activation of the autonomic nervous 
system caused by cholinesterase inhibitors 
suppressed LF power more than HF power. 
Cholinesterase inhibitors are known to ex-
ert unregulated and excessive stimulation 
of both muscarinic and nicotinic receptors 
in the central and autonomic nervous sys-
tems due to an accumulation of acetylcho-
line, and the symptoms are commonly re-
ferred to as ‘acute cholinergic crisis’. (11,22) 
Although the physiological basis for VLF 
power is far more complex than HF and LF 
power, with some authors recommending 
that VLF be used in the interpretation of 
short-term HRV data, (4) it has been sug-
gested that VLF power is associated with 
parasympathetic activity. (1) In our study, 
VLF was a significant predictor of poison-
ing by cholinesterase inhibitors. We specu-
late that VLF showed a promising result 
because cholinesterase inhibitors influence 
parasympathetic activity more potently 
than other clinical conditions studied pre-
viously.
The Poincaré plot is a nonlinear method 
for analyzing HRV data, which provides 
graphical understanding of beat-to-beat 
cycles and patterns not apparent in fre-
quency-domain analyses. (8) It is a scat-
terplot of the each R-R interval plotted 
against the preceding R-R interval. The 
standard deviation of points perpendicular 
to the line of identity (the width) represents 
short-term variation and is correlated with 
the root mean square successive difference 
(RMSSD). The standard deviation of points 
along the line of identity (length) repre-
sents long-term variation and is reported to 
represent parasympathetic blockade caused 
by complete denervation or atropine use. 
Complete denervation caused by cardiac 
transplantation produced a Poincaré plot 
of very small length and width, while at-
ropine infusion only reduced the width of 
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the Poincaré plot, resulting in an increased 
length/width ratio. (8,23) Our data show 
that the values derived from the Poincaré 
plot are not useful indicators of cholinest-
erase poisoning, and that the pattern itself 
is unlike previously reported atropine ef-
fects or denervation, which could possibly 
be explained by the fact that the autonomic 
disturbance caused by cholinesterase in-
hibitors represents an autonomic overload, 
unlike atropine-derived autonomic block-
ade. 
A number of studies have indicated the use-
fulness of HRV analysis in both emergency 
and nonemergency settings, and some have 
even suggested that HRV could be regarded 
as a new vital sign. (2 4,19,24,25) One of the 
major limitations of using HRV analysis 
in emergency situations is the complexity 
involved in processing and analyzing the 
HRV signal. (19) In this study, the time re-
quired to process HRV data from each case 
was largely dependent on the reliability of 
the automatic R-wave peak-detection al-
gorithm. Some cases had ECG waveforms 
that were hard to process using automatic 
methods, and considerable effort was need-
ed to manually verify and edit the R-R in-
terval data in these cases. Development of 
devices with automatic frequency-domain 
analysis along with reliable peak-detection 
algorithms would be required prior to 
widespread adoption of HRV analysis in 
emergency settings.
This study was limited by the small num-
ber of subjects. Although the total number 
of cases analyzed was 83, there were only 8 
positive cases. Our results should be con-
firmed by a larger study. Also, dose relation-
ships and HRV changes due to therapeutic 
measures should be studied. There are con-
cerns that emotion and other factors also 
contribute to the HRV results and therefore 
the ‘normal range’ is very wide. (1,4) The 
authors tried to minimize this confounding 
effect by comparing patients with others in 
the same emergency department setting 
rather than with previously reported nor-
mal ranges from healthy subjects.
Treatments, such as intravenous access or 
tracheal intubation, were given prior to 
HRV analysis. However, the limitation is 
unavoidable in an acute care setting, even 
for established diagnostic tests, where 
treatment takes priority over diagnosis. We 
tried to control for the confounding effect 
by utilizing multivariate logistic regression 
analysis.
Atropine is used to treat poisoning by 
cholinesterase inhibitors very early in the 
treatment course. Although atropine was 
used before the ECG signal was captured, 
our data reflect a very early condition be-
fore full atropinization was accomplished. 
A previous study revealed that parasympa-
thetic blockade by atropine decreased LF 
and HF power, (7) while our results found 
VLF power and the LF/HF ratio useful for 
diagnosing cholinesterase inhibitor poison-
ing. The pattern appearing on the Poincaré 
plot from cases of cholinesterase poisoning 
was unlike the previously reported atropine 
effect. Thus, HRV analysis in this study ex-
plains the effect of cholinesterase poisoning 
more than that of atropine. 
CONCLUSION
Frequency-domain analysis of heart rate 
variability showed significantly lower VLF 
power and LF/HF ratio in cases involving 
cholinesterase inhibitor poisoning com-
pared to other cases of intoxication in the 
early stages of emergency care.
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